Variability in Health Care Utilization and Perioperative Outcomes Among Urinary Diversion Patients: Analysis of the National Surgical Quality Improvement Program Database.

IF 1.7 Q4 UROLOGY & NEPHROLOGY
Urology Practice Pub Date : 2025-09-01 Epub Date: 2025-05-27 DOI:10.1097/UPJ.0000000000000839
Anthony Fadel, Bridget L Findlay, Alexander M Pinkhasov, Vidit Sharma, Katherine T Anderson, Boyd R Viers
{"title":"Variability in Health Care Utilization and Perioperative Outcomes Among Urinary Diversion Patients: Analysis of the National Surgical Quality Improvement Program Database.","authors":"Anthony Fadel, Bridget L Findlay, Alexander M Pinkhasov, Vidit Sharma, Katherine T Anderson, Boyd R Viers","doi":"10.1097/UPJ.0000000000000839","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Bladder cancer (BC) urinary diversion (UD) outcomes remain the benchmark to which all other UDs are compared. However, a sizable proportion are performed for other invasive cancers or benign etiologies of the bladder. We aim to compare health care utilization (HU) and 30-day morbidity among benign and malignant UD etiologies.</p><p><strong>Methods: </strong>The American College of Surgeons National Surgical Quality Improvement Program was used to collect data on 20,885 patients who underwent UD for various indications: BC, gastrointestinal/gynecologic cancer (GC), radiation (R), interstitial cystitis/benign bladder, and neurogenic bladder/bowel (NGB; assigned using International Classification of Diseases codes). Risk-adjusted regression models were developed to identify predictors of HU, prolonged length of stay (PLOS), 30-day readmissions, discharge to continued care (DCC), and morbidity (30-day complications and mortality). Frailty was also compared among different etiologies using the 5-Item Frailty Index.</p><p><strong>Results: </strong>Most patients had primary BC (91%, N = 19,060). GC had the highest complication rate (71%) and PLOS (50%), R had the highest readmission rate (23%), while NGB had the highest DCC (30%). GC was the least frail (≈14% with 5-Item Frailty Index ≥2) while NGB and R were the frailest (28% and 27%, respectively, <i>P</i> < .05). Moreover, frail radiated patients had the highest HU rate (81%, <i>P</i> < .001) while frail patients with GC had the highest complication rate (77%, <i>P</i> < .001). Compared with patients with BC, adjusted odds of PLOS, DCC, and 30-day complication rates significantly differed among UD etiologies (<i>P</i> < .05), except for interstitial cystitis/benign bladder.</p><p><strong>Conclusions: </strong>Postoperative HU and morbidity are greatly influenced by UD etiology. Care management in these vulnerable patient populations requires an individualized etiology-centered approach and cannot be benchmarked against those undergoing BC UD.</p>","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"548-556"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/UPJ.0000000000000839","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Bladder cancer (BC) urinary diversion (UD) outcomes remain the benchmark to which all other UDs are compared. However, a sizable proportion are performed for other invasive cancers or benign etiologies of the bladder. We aim to compare health care utilization (HU) and 30-day morbidity among benign and malignant UD etiologies.

Methods: The American College of Surgeons National Surgical Quality Improvement Program was used to collect data on 20,885 patients who underwent UD for various indications: BC, gastrointestinal/gynecologic cancer (GC), radiation (R), interstitial cystitis/benign bladder, and neurogenic bladder/bowel (NGB; assigned using International Classification of Diseases codes). Risk-adjusted regression models were developed to identify predictors of HU, prolonged length of stay (PLOS), 30-day readmissions, discharge to continued care (DCC), and morbidity (30-day complications and mortality). Frailty was also compared among different etiologies using the 5-Item Frailty Index.

Results: Most patients had primary BC (91%, N = 19,060). GC had the highest complication rate (71%) and PLOS (50%), R had the highest readmission rate (23%), while NGB had the highest DCC (30%). GC was the least frail (≈14% with 5-Item Frailty Index ≥2) while NGB and R were the frailest (28% and 27%, respectively, P < .05). Moreover, frail radiated patients had the highest HU rate (81%, P < .001) while frail patients with GC had the highest complication rate (77%, P < .001). Compared with patients with BC, adjusted odds of PLOS, DCC, and 30-day complication rates significantly differed among UD etiologies (P < .05), except for interstitial cystitis/benign bladder.

Conclusions: Postoperative HU and morbidity are greatly influenced by UD etiology. Care management in these vulnerable patient populations requires an individualized etiology-centered approach and cannot be benchmarked against those undergoing BC UD.

尿改道患者医疗保健利用和围手术期结局的变异性:NSQIP数据库的分析
导读:膀胱癌尿转移(UD)的结果仍然是所有其他UD比较的基准。然而,有相当大的比例是用于其他侵袭性癌症或膀胱良性病因。在这里,我们的目的是比较医疗保健利用和30天发病率在良性和恶性UD病因。方法:ACS-NSQIP收集了20,885例因各种适应症接受UD治疗的患者的数据:膀胱癌(BC)、GI/GYN癌(GC)、放疗(R)、间质性膀胱炎/良性膀胱(IB)和神经源性膀胱/肠(NGB)(使用ICD代码分配)。建立了风险调整回归模型,以确定医疗保健利用(HU)、住院时间延长(PLOS)、30天再入院(AR)、出院继续护理(DCC)和发病率(30天并发症和死亡率)的预测因子。使用五项虚弱指数(FFI)对不同病因的虚弱进行比较。结果:原发性膀胱癌患者占91% (N=19060)。GC组并发症发生率最高(71%),PLOS组最高(50%),R组再入院率最高(23%),NGB组DCC最高(30%)。GC最不脆弱(≈14%,FFI≥2),NGB和R最脆弱(28%和27%)。结论:UD的病因对术后HU和发病率有很大影响。这些弱势患者群体的护理管理需要个体化的病因为中心的方法,不能以接受BC UD的患者为基准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Urology Practice
Urology Practice UROLOGY & NEPHROLOGY-
CiteScore
1.80
自引率
12.50%
发文量
163
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信